Industry / United Kingdom

Novartis Follows Pfizer In Shutting Down Local Sites

March 2011 | Industry Trend Analysis

Printable version
Bookmark

The UK: An Attractive Location In Which To Sell Medicines

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Industry / United Kingdom BMI Core View: Governments will increasingly impose price controls on pharmaceuticals. Drugmakers have generally charged what the market will bear in both developed and emerging markets. High prices were...

March 2011

OTC Sector To Provide Revenue Earning Opportunities

Industry / United Kingdom BMI View: The UK's over-the-counter (OTC) medicines market is one of the most developed both in Europe and the world and is a pioneer in terms of switching drug status from prescription to OTC. It is also...

March 2011

Prescription Drug Charge To Rise

Industry / United Kingdom BMI View: While the sum of GBP450mn (US$728mn) - the income earned by the government as a result of the prescription charge in England - is relatively small when compared with its overall expenditure on...

March 2011

GSK 2010 Results Affected By Government Measures, Generic Competition And Legal Costs

Industry / United Kingdom BMI View: GlaxoSmithKline (GSK)'s 2010 results highlight the company's high exposure to healthcare sector cost-containment programmes and pricing pressures placed on medicines by governments in developed...

February 2011

GSK Enters Risk Sharing Agreement To Place Votrient On Market

Industry / United Kingdom BMI View: Drugmakers and governments will increasingly enter agreements to provide some form of risk sharing or price protection for new drugs.

January 2011